Exiting the EU: our work to ensure the best deal for cancer research and patients

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Brexit & the EU

Get in touch

To request a meeting or further information about our work please contact the Public Affairs team.

Email us

Health and science are global. And collaboration between the UK and countries in Europe and beyond enables the discoveries that benefit patients everywhere.

So we’ll be following progress on the UK’s new relationship with the EU closely. And we’ll continue to work hard to inform negotiations and ensure cancer patients in the UK and across the EU are prioritised in talks.

As the largest independent funder of research in Europe we remain committed to collaborating across borders within Europe, and globally, to beat cancer sooner.

What people affected by cancer need from the future relationship

We’ve been working to understand what people affected by cancer need from the future UK-EU relationship, and how we can amplify their voice during negotiations. The result is a short report, based on engagement and surveying of our communities, which we’re taking directly to Government

See more in our report

Scientists have greater impact when they collaborate internationally.

A report funded by eight leading UK medical research funders and charities identifies some of the main ways in which UK research contributes to medical progress. It highlights the benefit this has delivered for EU science, and ultimately how this has improved the health of patients across the EU.

Related documents

UK-EU negotiations and clinical research

The UK and EU: What people affected by cancer need from the future relationship

Crossborder Clinical Trials - How collaboration drives progress

The UK’s Future Relationship with the European Medicines Agency (October 2019)

No deal Brexit and implications for people affected by cancer - Letter from cancer charities (September 2019)

Cancer Research UK briefing - Opposition day debate on immigration (June 2019)

Cancer Research UK briefing for Westminster Hall debate on clinical trials (May 2019)

Cancer Research UK European Election briefing for prospective UK MEPs (May 2019)

Cancer Research UK response to MHRA consultation on EU exit no-deal proposals (November 2018)

Impact of a no deal Brexit - Cancer Research UK submission to Health and Social Care Committee inquiry (October 2018)

CRUK Policy Position: Summary of Brexit priorities (September 2018)

Cancer Research UK briefing - European regulatory system for medicines (September 2018)

Cancer Research UK’s policy statement on clinical trials as the UK exits the EU (August 2018)

The Future of Clinical Trials After Brexit report (August 2018)

The Future of Clinical Trials After Brexit slide deck (August 2018)

Response to the House of Commons Science and Technology Committee (June 2018)

Cancer charity joint letter: Priorities for second phase Brexit negotiations

CRUK policy position: Clinical Trials Regulation

CRUK Policy position: Drug licensing

CRUK Policy position: Researcher mobility (May 2018)

Campaign for us

Rate this page:

Currently rated: 2.8 out of 5 based on 21 votes
Thank you!
We've recently made some changes to the site, tell us what you think